Why Is Soligenix Stock Sinking Tuesday?

On Tuesday, Soligenix Inc. (NASDAQ:SNGX) said its pivotal Phase 3 FLASH2 trial evaluating HyBryte in cutaneous T-cell lymphoma (CTCL) will be halted after an interim analysis recommended stopping the study for futility, marking a setback for the late-stage...

Dow Gains 150 Points; Coca-Cola Posts Upbeat Earnings

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.27% to 49,299.31 while the NASDAQ fell 1.06% to 24,622.60. The S&P 500 also fell, dropping, 0.52% to...